A wave of consumer class action lawsuits is proving that routine website analytics practices may create major litigation exposure for businesses. Companies that use technologies such as Meta Pixel, Google Analytics, session replay software, chat features, and behavioral tracking tools are now defending themselves against claims that they improperly collected or shared consumer data without consent.
What began as a niche privacy issue has quickly evolved into a small, burgeoning cottage industry of consumer litigation threats.
Many of the lawsuits cite decades-old wiretap and privacy statutes that plaintiffs’ attorneys are applying to today’s website technologies.
The core allegation is generally straightforward: a company allegedly allowed third-party tracking technologies to intercept or collect user communications without proper disclosure or consent.
Plaintiffs in these cases posit that website interactions such as search activity, form submissions, purchase behavior, and chat communications constitute protected communications under state privacy laws. The litigation wave has accelerated dramatically as companies in a myriad of industries increasingly rely on user analytics tools to augment their digital marketing programs.
An early influential case in this evolving area was the Facebook Internet Tracking Litigation, in which plaintiffs alleged that Facebook improperly tracked users’ browsing activity after they logged out of the platform. The Ninth Circuit permitted portions of the claims to proceed under federal and state privacy laws, helping establish broader judicial willingness to entertain internet tracking claims.
Case link:
In re Facebook Internet Tracking Litigation Decision: 17-17486.pdf
Several factors have ignited the uptick in website tracking litigation.
First, nearly every business uses some form of tracking or analytics technology, so a target-rich environment exists. Second, privacy statutes in states such as California, Pennsylvania, and Florida can provide statutory damages or favorable class certifications. Third, plaintiffs often argue that consumers were unaware of the extent of data collection occurring as they interacted with websites. Therefore, businesses may face substantial exposure even when there is no allegation that data was sold or intentionally misused.
Plaintiffs’ firms have increasingly relied on legislation such as the California Invasion of Privacy Act (“CIPA”) to argue that common website tracking technologies constitute unlawful “eavesdropping” or interception of communications. One closely watched example is Camplisson v. Adidas America, Inc., where plaintiffs alleged that tracking pixels embedded on the Adidas website collected user-identifying routing and device information without consent. The court denied Adidas’s motion to dismiss, allowing the CIPA claim to proceed, underscoring how plaintiffs are using older wiretap and pen-register concepts to challenge modern website analytics tools.
Case link:
Camplisson v. Adidas America, Inc.: https://docs.justia.com/cases/federal/district-courts/california/casdce/3:2025cv00603/807817/32
Healthcare organizations have become especially prominent targets. Hospitals and healthcare providers have faced lawsuits alleging that website tracking tools improperly transmitted protected patient information to third parties via online appointment systems, symptom searches, and patient portals.
The ongoing Meta Pixel Healthcare Litigation wave has become one of the defining developments in digital privacy litigation. Plaintiffs have alleged that healthcare providers improperly shared sensitive patient information through Meta Pixel implementations embedded into hospital websites and patient-facing portals.
These lawsuits demonstrate how even routine analytics tools may create significant exposure where consumer or patient data is involved.
Example litigation overview:
Meta Pixel Healthcare Litigation Overview: https://natlawreview.com/article/litigation-minute-pixel-tools-health-care-arena
Financial institutions may also face substantial scrutiny when their websites collect consumer data. Recent class action lawsuits filed against Wells Fargo and PNC Bank allege that the banks used website tracking technologies, including pixels and other online tracking tools, to transmit consumers’ browsing activity and financial-interest data to third-party advertising companies without consent. The complaints assert violations of California privacy laws, including the California Invasion of Privacy Act (“CIPA”), underscoring the growing litigation risk facing financial institutions that deploy advertising and analytics technologies on consumer-facing websites.
These lawsuits reflect the expanding use of traditional privacy and wiretap statutes to challenge ordinary website advertising and analytics practices in the financial services industry.
These lawsuits reflect a broader shift in consumer class action strategy.
Plaintiffs firms increasingly focus on:
In many cases, the litigation risk stems not from malicious conduct, but from the widespread adoption of third-party software tools embedded into websites for marketing and analytics purposes. That unintended consequence makes these lawsuits particularly dangerous as many companies lack the in-house capability to understand the depth of the information mined by the data collection technologies that operate within their own websites. They often contract with vendors to select and install analytics tools that capture visitor data while ignorant of the risks associated with how the products perform.
The litigation trend has also expanded beyond private lawsuits into federal regulatory scrutiny. In 2023, the Federal Trade Commission (FTC) announced a significant enforcement action against GoodRx, alleging that the company improperly shared consumers’ sensitive health information with advertising platforms including Meta and Google.
FTC action link:
https://www.ftc.gov/news-events/news/press-releases/2023/02/ftc-enforcement-action-bar-goodrx-sharing-consumers-sensitive-health-info-advertising
The FTC’s action demonstrates that regulators are examining how businesses collect data and how tracking technologies interact with advertising platforms.
Regulators and courts are increasingly focused on digital privacy practices. The FTC has intensified its review of online data practices while courts are interpreting how decades-old privacy statutes apply to evolving cyber and AI technologies.
Another important decision in the online consent arena is Javier v. Assurance IQ, in which the plaintiff alleged that an insurance website used session replay technology to secretly record his interactions, including keystrokes and personal information, before he consented to the site’s privacy policy. The Ninth Circuit held that under California’s wiretap law (CIPA), consent must be obtained before the recording occurs. The ruling highlights growing judicial examination of digital consent mechanisms and reinforces the importance of clear website disclosures and user consent.
Case link:
Javier v. Assurance IQ, LLC: https://law.justia.com/cases/federal/appellate-courts/ca9/21-16351/21-16351-2022-05-31.html
Although legal standards remain unsettled in some jurisdictions, courts are increasingly allowing these claims to survive early dismissal challenges, creating significant settlement pressure for businesses of varying sizes and industries.
Given the growing environment for litigation arising from online data collection practices, businesses should proactively evaluate their digital privacy exposure to mitigate potential legal exposure.
Such initiatives may include:
Privacy compliance can no longer be viewed simply as an IT function. It is now a serious litigation and enterprise reputation matter.
The rise of website tracking litigation illustrates the vulnerability that businesses share (regardless of size) arising from their lack of understanding of new technologies that capture consumer data. Consumer class action strategy is evolving in lock step with the broad adoption of web-based data collection tools.
Practices once viewed as standard digital marketing operations are now a gateway to substantial litigation exposure. For businesses, the lesson is increasingly difficult to ignore: consumer privacy litigation is no longer a niche concern reserved for large technology companies. Instead, it is rapidly becoming a mainstream business risk with potentially significant financial and reputational consequences.
A recent federal court decision rejecting a consumer’s claims concerning a popular infant formula provides an important reminder about the challenges inherent in prosecuting omission-based claims.
In Huggins v. Abbott Laboratories, the Northern District of Illinois dismissed claims alleging that the manufacturer misled consumers by failing to disclose the presence of heavy metals in the infant formula. The court found that plaintiffs failed to prove that reasonable consumers would interpret the product packaging as representing the absence of such substances.
The Court’s reasoning is important: Consumer protection claims are typically not based on what a company could have said. They are based on what a reasonable consumer would understand is communicated from the product packaging.
For businesses — particularly those operating in highly scrutinized consumer sectors such as health-related consumables — the decision reinforces that omission theories require a clear and unmistakable communication from consumer-facing messaging.
However, with litigation remaining robust in these areas, companies should consider this case as an opportunity to examine and refine their own disclosure strategies, not relax them.
The strongest defense for a manufacturer is not simply compliance; it is accuracy, transparency, and clarity in how products are described, marketed, and understood by the consumer.
Case Reference:
Huggins et al. v. Abbott Laboratories, No. 1:25-cv-02460 (N.D. Ill. Apr. 2026)
Simple product claims may carry complex legal consequences.
In Flaherty v. Kenvue Brands LLC, the Northern District of Illinois allowed claims to proceed against a major skincare manufacturer over its “oil-free” labeling. The court held that plaintiffs plausibly alleged that a reasonable consumer could interpret “oil-free” according to that exact meaning.
That conclusion was enough to defeat a motion to dismiss.
For companies, this is where risk often hides in plain sight. Words like “free,” “natural,” “pure,” “clean,” or “clinically proven” are powerful product descriptors but are also frequent targets in consumer class actions.
Courts evaluating these claims are not always persuaded by technical or scientific nuance. Instead, they often consider how a reasonable consumer would understand the language on the label, and the reasonable meaning associated with it.
The takeaway is straightforward: the more objective the claim appears, the stronger the substantiation required.
Marketing, product, and legal teams must align before product descriptions reach consumer shelves. A single word or phrase can anchor a lawsuit — and survive dismissal.
Case Reference:
Flaherty v. Kenvue Brands LLC, No. 1:20-cv-07255 (N.D. Ill. Mar. 25, 2026)
https://law.justia.com/cases/federal/district-courts/illinois/ilndce/1:2020cv07255/393898/69/
A recent federal decision involving the popular and ever-present Stanley tumblers is a striking illustration that litigation risk and reputational risk do not always move in lockstep.
In April 2026, the U.S. District Court for the Western District of Washington dismissed for the second time (albeit with leave to amend yet again) claims alleging that the manufacturer failed to disclose the presence of lead in its products — in this case a lead pellet encased in stainless steel that assists in insulating the tumbler. The court granted the manufacturer’s motion to dismiss, finding that the plaintiffs failed to plausibly allege a meaningful risk of harm or a materially misleading omission.
The court’s reasoning is instructive: the presence of a hazardous material without a plausible pathway to consumer exposure is not enough to sustain an actionable claim. Courts continue to require more concrete proof of a risk of harm, than mere speculation about the product’s potential for harm.
For consumer brands, this decision highlights a critical operational reality. The presence of lead in the wildly popular Stanley tumblers had become the subject of numerous social media posts across Instagram, YouTube, Reddit and other platforms, ultimately resulting in Stanley posting an on-line statement on its website addressing the situation. When a product becomes the subject of viral scrutiny, the legal question is not simply whether the concern is warranted and needs to be addressed publicly, but how that concern might be translated to an actionable lawsuit.
Companies that weave their legal, compliance, and crisis communications into a cohesive tapestry are far better positioned to respond effectively to consumer concerns and potential misunderstandings related to the manufacture and performance of their products, than are companies that ignore the groundswell of on-line concern.
The Stanley decision is a reminder: reputational crises often move quickly, but successful litigation depends entirely on disciplined pleading and provable risk.
Case Reference:
In re Pacific Market International, LLC, Stanley Tumbler Litigation (W.D. Wash. Apr. 2026)
